Principles and Practice of Pharmaceutical Medicine / Edition 2

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $468.36
Usually ships in 1-2 business days
Other sellers (Hardcover)
  • All (1) from $468.36   
  • New (1) from $468.36   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$468.36
Seller since 2011

Feedback rating:

(881)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
Brand new and unread! Join our growing list of satisfied customers!

Ships from: Phoenix, MD

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
Page 1 of 1
Showing All
Close
Sort by

Overview

The long awaited second edition of Principles and Practice of Pharmaceutical Medicine provides an invaluable guide to all areas of drug development and medical aspects of marketing. The title has been extensively revised and expanded to include the latest regulatory and scientific developments. New chapters include:
  • European Regulations
  • Ethics of Pharmaceutical Medicine
  • Licensing and Due Diligence
  • Pharmacogenomics

Encompassing the entire spectrum of pharmaceutical medicine, it is the most up-to-date international guide currently available.

Review of the first edition:

“This book was a joy to read and a joy to review. All pharmaceutical physicians should have a copy on their bookshelves, all pharmaceutical companies should have copies in their libraries.”
—BRITISH ASSOCIATION OF PHARMACEUTICAL PHYSICIANS

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Patrick J McDonnell, Pharm.D.(Temple University School of Pharmacy)
Description: This is a truly fine book on the development of pharmaceutics from drug discovery and development to regulatory, business, legal, and ethical issues.
Purpose: The purpose is to provide an overview of pharmaceutical medicine to pharmaceutical physicians, pharmacists, and others working or having an interest in this area. The introductory chapter by editor and author Anthony W. Fox explains what this specialty is in the realm of medicine, how drugs are developed, studied, brought to market, and monitored in a post-marketing setting. The book meets these objectives, not only providing an overview, but delving into areas readers may find useful.
Audience: The audience is as broad as the spectrum of chapters. As a pharmacy educator, I feel it would be an excellent reference for pharmacy students, as well as others in healthcare who may not realize the intensity of the drug development process and the effort that goes into bringing a drug to market. The editors are leaders in the pharmaceutical industry and academia.
Features: Chapters introduce the stages of drug study, protocols, monitoring, and regulation. Nuances in different patient populations are covered in a welcome addition, focusing on the elderly, children, patients with renal and hepatic impairment, and significant drug interactions. These populations often are not included in clinical trials, but, of course, use drug therapies. Despite the lack of a complete list of references for the chapters, I was pleasantly surprised how much the book covered.
Assessment: This is a useful book for those who want a behind the scenes look at how drugs used in their clinical practices come to market. As types of drug therapies are developed and researched, future updates covering issues with new therapies will be necessary.
From the Publisher
"The authors provide a one-stop international guide to the various aspects of drug development." (The Pharmaceutical Journal, 2008)

"…this text should serve as a useful instructional tool in the classroom for those entering this medical specialty and as a field guide to those already working in the industry." (Journal of the American Medical Association, June 25, 2008)

"…a truly fine book on the development of pharmaceuticals…useful book for those who want a behind the scenes look…" (Doody's Health Services)

Read More Show Less

Product Details

  • ISBN-13: 9780470093139
  • Publisher: Wiley, John & Sons, Incorporated
  • Publication date: 6/15/2007
  • Edition description: REV
  • Edition number: 2
  • Pages: 780
  • Product dimensions: 7.70 (w) x 9.90 (h) x 2.00 (d)

Meet the Author

Lionel D Edwards.  MB, BS, LRCP, MRCS, DipRCOG, FFPM, is Senior Director of Medical Affairs for Novartis USA, and President of Pharma Pro Plus Inc., a drug development consulting company. Dr. Edwards has been involved in all aspects of clinical trials for over 33 years on many different research drug and devices in 10 therapeutic areas.  Dr. Edwards is a Fellow of the Faculty of Pharmaceutical Medicine and an Adjunct Professor at Temple University Graduate School of Pharmacology. He has taught for the Pharmaceutical Education & Research Institute for over 12 years and was on the teaching faculty of the National Association of Physicians. He is a founder member of the American Academy of Pharmaceutical Physicians. 

Anthony W Fox. BSc, MBBS, FFPM, FRCP, MD(Lond), DipPharmMedRCP, CBiol, FIBiol, FRSA is President of EBD Group, a consultancy with offices in San Diego and Munich. Tony is a liveryman guardant of the Worshipful Society of Apothecaries of London.  He is an Adjunct (i.e., honorary) Associate Clinical Professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences, at the University of California, San Diego.  His publications span several areas of pharmaceutical medicine, e.g. regulation, pharmacology, clinical trials, pharmacovigilance, analgesics, migraine, genotoxicology, and metabolism, and he is named as inventor on several patents. He is on the editorial boards of several journals, and serves in a more senior capacity for two of them.

Peter D Stonier.  BA, BSc, PhD, MBChB, MRCPsych, FRCP, FRCPE, FFPM has 29 years experience in pharmaceutical medicine. Peter is Director of Education and Training of the Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians of the UK. He is Medical Director of Amdipharm Plc, and of Medical Resource Provider Axess Ltd, and Visiting Professor in pharmaceutical medicine at the University of Surrey, which under his direction introduced the first MSc degree in Pharmaceutical Medicine in 1993, which is now part of the Postgraduate Medical School of the University. His publications include edited works in human psychopharmacology, pharmaceutical medicine, clinical research, medical marketing, and careers in the pharmaceutical industry. He is a member of the Association of Pharmaceutical Physicians and Investigators (APPI). Professor Stonier has been elected a Fellow of the Royal Society for the encouragement of Arts, Manufactures and Commerce.

Andrew J. Fletcher.  MB, BChir, (Cantab), MS (Columbia), FFPM, DipPharmMedRCP, was formerly the Senior Assistant Editor of The Merck Manual, and is Adjunct Professor of Pharmaceutical Health Care at Temple University School of Pharmacy. He teaches pharmaceutical medicine, bioethics, and medical and scientific writing at Temple University’s School of Pharmacy. He is a founder member and former trustee of the Academy of Pharmaceutical Physicians and Investigators (formerly the American Academy of Pharmaceutical Physicians).

Read More Show Less

Table of Contents

Preface to the First Edition.

Preface to the Second Edition.

About the Editors.

Contributors.

SECTION I: OVERVIEW OF PHARMACEUTICAL MEDICINE.

1. The Practice and Practitioners of Pharmaceutical Medicine (Anthony W. Fox).

2. Pharmaceutical Medicine as a Medical Specialty (Michael D. Young and Peter D. Stonier).

3. Clinical Research Education and Training for Biopharmaceutical Staff (Peter Marks).

SECTION II: DRUG DISCOVERY AND DEVELOPMENT.

Introduction.

4. Drug Discovery: Design and Serendipity (Ronald R. Cobb and J. Leslie Molony).

5. Pharmaceutics (Anthony W. Fox).

6. Non-clinical Toxicology (Frederick Reno).

7. Informed Consent (Anthony W. Fox).

8. Phase I: The First Opportunity for Extrapolation from Animal Data to Human Exposure (Stephen H. Curry, Dennis McCarthy, Heleen H. DeCory, Matthew Marler and Johan Gabrielsson).

9. Phase II and Phase III Clinical Studies (Anthony W. Fox).

10. Phase IV Drug Development: Post-Marketing Studies (Lisa R. Johnson-Pratt).

11. Site Management (Barry Miskin).

12. Good Clinical Practices (Wendy Bohaychuk and Graham Ball).

13. Quality Assurance, Quality Control, and Audit (Rita Hattemer-Apostel).

14. The Unique Role of Over-the-counter Medicine (Paul Starkey).

SECTION III: SPECIAL POPULATIONS AND REQUIRED SPECIAL STUDIES.

Introduction.

15. Drug Research in Older Patients (Lionel D. Edwards).

16. Drug Development Research in Women (Lionel D. Edwards.

17. Clinical Research in Children (Lionel D. Edwards).

18. Racial and Ethnic Issues in Drug Registration (Lionel D. Edwards, J.M. Husson, Etienne Labb‚, C. Naito, M. Papaluca Amati, S. Walker, R. Williams and H. Yasurhara).

19. Hepatic and Renal Failure (Anthony W. Fox).

20. Drug Interactions (Anthony W. Fox and Anne-Ruth van Troostenburg de Bruyn).

21. Orphan Drugs (Bert Spilker).

SECTION IV: APPLIED ASPECTS OF DRUG DEVELOPMENT.

INTRODUCTION

22. Biotechnology Products and Development (David A. Shapiro and Anthony W. Fox).

23. Pharmacoeconomics: Economic and Humanistic Outcomes (Raymond J. Townsend, Jane T. Osterhaus and J. Gregory Boyer).

24. Pharmacoepidemiology and the Pharmaceutical Physician (Hugh H. Tilson).

25. Statistical Principles and Application in Biopharmaceutical Research (Dan Anbar).

26. Data Management (T.Y. Lee and Michael Minor).

27. Patient Compliance: Pharmionics, A New Discipline (Jean-Michel Métry).

28. Monitoring Drug Concentrations in Clinical Practice (Anthony W. Fox).

29. Generics (Gabriel Lopez and Thomas Hoxie).

30. Complementary Medicines (Anthony W. Fox).

SECTION V: DRUG REGULATION.

Introduction.

31. United States Regulations (William Kennedy).

32. Special US Regulatory Procedures:  Emergency and Compassionate INDs and Accelerated Product Approvals (Anthony W. Fox).

33. The Development of Human Medicines Control in Europe From Classical Times to the Year 2000 (John P. Griffin).

34. Medicines Regulation in the European Union (Anne-Ruth van Troostenburg de Bruyn and Giuliana Tabusso).

35. Japanese Regulations (Etienne Labb).

36. Drug Registration and Pricing in the Middle East (Edda Freidank-Müschenborn and Anja König).

SECTION: VI: MEDICAL SERVICES.

Introduction.

37. Medical Affairs (Gregory P. Geba).

38. Drug Labeling (Anthony W. Fox).

39. Drug Surveillance (Howard J. Dreskin and Win M. Castle).

40. Data Mining (Mirza Rahman and Omar H. Dabbous).

41. Risk Management in Product Approval and Marketing (Anthony W. Fox).

42. Publishing Clinical Studies (Anthony W. Fox).

43. Organizing and Planning Local, Regional, National, and International Meetings and Conferences (Zofia Dziewanowska and Linda Packard).

44. Drug Withdrawals from the Market - Causes and Consequences (Ronald D. Mann).

SECTION VII: LEGAL AND ETHICAL ASPECTS OF PHARMACEUTICAL MEDICINE. 

Introduction.

45. Introduction to Bioethics for Pharmaceutical Professionals (Andrew J. Fletcher).

46. Pharmaceutical Medicine and the Law (Sara Croft and Timothy Pratt).

47. Pharmaceutical Product Liability (Han W. Choi and Howard B. Yeon).

48. Patents (Gabriel Lopez).

49. Fraud and Misconduct in Clinical Research (Jane Barrett).

SECTION VIII: BUSINESS ASPECTS.

Introduction.

50. The Multinational Corporations: Cultural Challenges, the Legal/Regulatory Framework and the Medico-commercial Environment (R. Drucker and R. Graham Hughes).

51. Advertising and Marketing (Jonathan Belsey).

52. Pharmaceutical Medicine in the East (Gamal Hammad).

53. Financial Aspects of Clinical Trials (R. Graham Hughes and Nadia Turner).

54. Outsourcing Clinical Drug Development Activities to Contract Research. Organizations (CROs): Critical Success Factors (John R. Vogel).

55. The Impact of Managed Care on the Pharmaceutical Industry (Robert J. Chaponis, Christine Hanson-Divers and Marilyn J. Wells).

Appendix--Useful Internet Links.

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)